These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25888939)

  • 1. Human and murine prostate basal/stem cells are not direct targets of prolactin.
    Sackmann-Sala L; Angelergues A; Boutillon F; d'Acremont B; Maidenberg M; Oudard S; Goffin V
    Gen Comp Endocrinol; 2015 Sep; 220():133-42. PubMed ID: 25888939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.
    Rouet V; Bogorad RL; Kayser C; Kessal K; Genestie C; Bardier A; Grattan DR; Kelder B; Kopchick JJ; Kelly PA; Goffin V
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15199-204. PubMed ID: 20699217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin-induced prostate tumorigenesis.
    Sackmann-Sala L; Goffin V
    Adv Exp Med Biol; 2015; 846():221-42. PubMed ID: 25472541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
    Boutillon F; Pigat N; Sala LS; Reyes-Gomez E; Moriggl R; Guidotti JE; Goffin V
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31269779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-induced prostate tumorigenesis links sustained Stat5 signaling with the amplification of basal/stem cells and emergence of putative luminal progenitors.
    Sackmann-Sala L; Chiche A; Mosquera-Garrote N; Boutillon F; Cordier C; Pourmir I; Pascual-Mathey L; Kessal K; Pigat N; Camparo P; Goffin V
    Am J Pathol; 2014 Nov; 184(11):3105-19. PubMed ID: 25193592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
    Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
    Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
    Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.
    Kindblom J; Dillner K; Sahlin L; Robertson F; Ormandy C; Törnell J; Wennbo H
    Endocrinology; 2003 Jun; 144(6):2269-78. PubMed ID: 12746285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.
    Thomas LN; Merrimen J; Bell DG; Rendon R; Goffin V; Too CK
    Prostate; 2014 May; 74(7):732-42. PubMed ID: 24615730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
    Xu X; Kreye E; Kuo CB; Walker AM
    Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
    Goffin V
    Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in prolactin receptor location in prostate tumors.
    López Fontana G; Rey L; Santiano F; López Fontana R; López Laur JD; Zyla L; Valdemoros P; Guerrero-Giménez ME; Fernández-Muñoz JM; Gómez S; Bruna F; Guglielmi JM; Carón R; López Fontana C
    Arch Esp Urol; 2021 May; 74(4):419-426. PubMed ID: 33942735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and the prolactin receptor: new targets of an old hormone.
    Harris J; Stanford PM; Oakes SR; Ormandy CJ
    Ann Med; 2004; 36(6):414-25. PubMed ID: 15513293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures.
    Ueda EK; Huang K; Nguyen V; Ferreira M; Andre S; Walker AM
    Cell Tissue Res; 2011 Nov; 346(2):175-89. PubMed ID: 22081226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells.
    Wu W; Ginsburg E; Vonderhaar BK; Walker AM
    Cancer Res; 2005 Aug; 65(16):7509-15. PubMed ID: 16103106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Plasticity in a Mouse Model of Benign Prostate Hyperplasia Drives Amplification of Androgen-Independent Epithelial Cell Populations Sensitive to Antioxidant Therapy.
    Dos Santos L; Carbone F; Pacreau E; Diarra S; Luka M; Pigat N; Baures M; Navarro E; Anract J; Barry Delongchamps N; Cagnard N; Bost F; Nemazanyy I; Petitjean O; Hamaï A; Ménager M; Palea S; Guidotti JE; Goffin V
    Am J Pathol; 2024 Jan; 194(1):30-51. PubMed ID: 37827216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of prolactin levels and PRL-receptor expression with Stat and Mapk cell signaling in the prostate of long-term sexually active rats.
    Rojas-Durán F; Pascual-Mathey LI; Serrano K; Aranda-Abreu GE; Manzo J; Soto-Cid AH; Hernandez ME
    Physiol Behav; 2015 Jan; 138():188-92. PubMed ID: 25446202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways: blockade of the PRLR signaling pathway as a novel antihormonal approach for the treatment of breast and prostate cancer.
    Damiano JS; Wasserman E
    Clin Cancer Res; 2013 Apr; 19(7):1644-50. PubMed ID: 23515410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
    Li H; Ahonen TJ; Alanen K; Xie J; LeBaron MJ; Pretlow TG; Ealley EL; Zhang Y; Nurmi M; Singh B; Martikainen PM; Nevalainen MT
    Cancer Res; 2004 Jul; 64(14):4774-82. PubMed ID: 15256446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
    Jabbour HN; Critchley HO; Boddy SC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.